K230023

Substantially Equivalent

ART-Plan

Applicant: Therapanacea Sas
Product code: QKB
Advisory panel: Radiology
Date received: 2023-01-04
Decision date: 2023-04-19
Decision: Substantially Equivalent
Clearance type: Special
Location: Paris, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.